311 related articles for article (PubMed ID: 16892895)
41. [Late treatment related complications of Hodgkin's disease].
Henry-Amar M; Gisselbrecht C
Rev Prat; 1998 May; 48(10):1092-7. PubMed ID: 9781154
[TBL] [Abstract][Full Text] [Related]
42. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
Won SC; Han JW; Kwon SY; Shin HY; Ahn HS; Hwang TJ; Yang WI; Lyu CJ
Ann Hematol; 2006 Nov; 85(11):787-94. PubMed ID: 16932891
[TBL] [Abstract][Full Text] [Related]
43. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
44. [The condition of long-term survivors and patients cured of childhood neoplasms].
Gutjahr P
Fortschr Med; 1980 Feb; 98(8):289-92. PubMed ID: 6247258
[TBL] [Abstract][Full Text] [Related]
45. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
Kuleva SA
Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
[TBL] [Abstract][Full Text] [Related]
46. [Some aspects of reproductive function and social adaptation after comprehensive therapy of childhood Hodgkin's disease].
Susuleva NA; Il'iashenko VV
Vopr Onkol; 1997; 43(4):399-402. PubMed ID: 9381688
[TBL] [Abstract][Full Text] [Related]
47. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
48. Non-Hodgkin's lymphoma of Waldeyer's ring in children: outcome using chemotherapy and involved field radiotherapy.
Laskar S; Bahl G; Muckaden MA; Pai S; Nair R; Gupta S; Shet T; Gujral S; Arora B; Sengar M; Shrivastava SK; Dinshaw KA
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):613-8. PubMed ID: 18585015
[TBL] [Abstract][Full Text] [Related]
49. Radiation therapy in Hodgkin's lymphoma.
Ng AK; Mauch PM
Semin Hematol; 1999 Jul; 36(3):290-302. PubMed ID: 10462329
[TBL] [Abstract][Full Text] [Related]
50. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
[TBL] [Abstract][Full Text] [Related]
51. [Quality of life during and following radiochemotherapy for Hodgkin's disease. Evaluation of 60 patients].
Hoerni B; Hoerni-Simon G; Eghbali H; Richaud P
Bull Cancer; 1983; 70(4):284-8. PubMed ID: 6652248
[TBL] [Abstract][Full Text] [Related]
52. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
53. [Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
Ben Hassouna J; Slimène M; Boussen H; Bouzaiene H; Khomsi F; Chargui R; Kochbati L; Mtaallah MH; Gamoudi A; Benna F; Hechiche M; Rahal K
Gynecol Obstet Fertil; 2007 Jun; 35(6):536-40. PubMed ID: 17543568
[TBL] [Abstract][Full Text] [Related]
54. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
55. Thyroid volume is progressively reduced as a sequela of neck irradiation for childhood Hodgkin's disease.
Bossi G; Larizza D; Sommaruga G; Corbella F; Klersy C; Aricò M
Haematologica; 1998 Aug; 83(8):754-6. PubMed ID: 9793265
[TBL] [Abstract][Full Text] [Related]
56. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
[TBL] [Abstract][Full Text] [Related]
57. Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial.
Capra M; Hewitt M; Radford M; Hayward J; Weston CL; Machin D;
Eur J Cancer; 2007 May; 43(7):1171-9. PubMed ID: 17379506
[TBL] [Abstract][Full Text] [Related]
58. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
Aleman BM; van Leeuwen FE
Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
[TBL] [Abstract][Full Text] [Related]
59. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge.
Buysse CM; Raat H; Hazelzet JA; Hop WC; Maliepaard M; Joosten KF
Crit Care Med; 2008 Feb; 36(2):596-602. PubMed ID: 18216608
[TBL] [Abstract][Full Text] [Related]
60. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.
Hancock SL; Hoppe RT
Semin Radiat Oncol; 1996 Jul; 6(3):225-242. PubMed ID: 10717180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]